Future Science Group
Supplementary material.docx (333.3 kB)

Atorvastatin-loaded peptide amphiphiles against corneal neovascularization - supplementary material

Download (333.3 kB)
posted on 2023-08-23, 11:45 authored by Elena Sanchez-Lopez, Maria Jose Gomara, Isabel Haro

Background: Corneal neovascularization is a sight-threatening disease. It can be treated using antiangiogenic and anti-inflammatory compounds. Therefore, atorvastatin (ATV) constitutes a suitable candidate to be administered topically. To attain suitable efficacy, ATV can be encapsulated into custom developed nanocarriers such as peptide amphiphiles. Methods: Three peptide amphiphiles bearing one, two or four C16-alkyl groups (mC16-Tat47-57, dC16-Tat47-57 and qC16-Tat47-57) were synthesized, characterized and loaded with ATV. Drug release and ocular tolerance were assessed as well as anti-inflammatory and antiangiogenic properties. Results: ATV-qC16-Tat47-57 showed higher encapsulation efficiency than mC16- Tat47-57 and dC16-Tat47-57 and more defined nanostructures. ATV-qC16-Tat47-57 showed ATV prolonged release with suitable ocular tolerance. Moreover, ATV-qC16-Tat47-57 was antiangiogenic and prevented ocular inflammation. Conclusion: ATV-qC16-Tat47-57 constitutes a promising topical medication against corneal neovascularization.


Spanish Ministry of Economy, Industry and Competitiveness , (Grant / Award Number: 'RTI2018-094120-B-I00, PID2021-122216OB-I00 and PID')


Usage metrics